Literature DB >> 13012024

Phenylbutazone (butazolidine) in the treatment of chronic arthritis.

L CUDKOWICZ, J H JACOBS.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; ARTHRITIS, RHEUMATOID/therapy; OSTEOARTHRITIS/therapy

Mesh：

Substances：

Year:  1953        PMID： 13012024     DOI： 10.1016/s0140-6736(53)90891-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Hepatic necrosis and other visceral lesions associated with phenylbutazone therapy.

Authors:  J M MACCARTHY; R T JACKSON
Journal:  Br Med J       Date:  1955-07-23

2.  An appraisal of phenylbutazone suppositories.

Authors:  C F HAWKINS; H T FAWNS
Journal:  Br Med J       Date:  1959-10-17

3.  Toxic effects of phenylbutazone with special reference to disorders of the blood.

Authors:  J C LEONARD
Journal:  Br Med J       Date:  1953-06-13

4.  Toxic effects of phenylbutazone.

Authors:  J R NASSIM; T PILKINGTON
Journal:  Br Med J       Date:  1953-06-13

5.  Peptic ulcer perforation after phenylbutazone therapy.

Authors:  E CHRISTENSEN
Journal:  Br Med J       Date:  1954-10-16

6.  Multiple visceral lesions due o phenylbutazone toxicity.

Authors:  J R NASSIM
Journal:  Br Med J       Date:  1954-10-30

7.  Phenylbutazone and renal function.

Authors:  B M JOHNSON; I M LARKIN
Journal:  Br Med J       Date:  1954-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.